| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/16/2003 | CA2481318A1 Identification of virulence associated regions rd1 and rd5 leading to improve vaccine of m. bovis bcg and m. microti |
| 10/16/2003 | CA2481090A1 Novel pancortin-pablo protein interactions and methods of use thereof |
| 10/16/2003 | CA2481039A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 10/16/2003 | CA2480996A1 Peptides derived or obtained from cytokine and the application thereof in therapy |
| 10/16/2003 | CA2480811A1 Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer |
| 10/16/2003 | CA2480786A1 Recombinant p. falciparum merozoite protein-142 vaccine |
| 10/16/2003 | CA2480692A1 Chemokines mutants having improved oral bioavailability |
| 10/16/2003 | CA2480598A1 Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof |
| 10/16/2003 | CA2480504A1 Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell |
| 10/16/2003 | CA2480450A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 10/16/2003 | CA2480084A1 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
| 10/16/2003 | CA2479049A1 Nucleic acid and corresponding protein entitled 238p1b2 useful in treatment and detection of cancer |
| 10/16/2003 | CA2478930A1 Epitope constructs comprising antigen presenting cell targeting mechanisms |
| 10/16/2003 | CA2477935A1 Multivalent constructs for therapeutic and diagnostic applications |
| 10/16/2003 | CA2477421A1 Novel promoter |
| 10/15/2003 | EP1352975A2 Selection of sites for targeting by zinc finger proteins and methods of designing zinc fingers proteins to binds to preselected sites |
| 10/15/2003 | EP1352962A1 186 human secreted proteins |
| 10/15/2003 | EP1352961A1 Synovial cell protein |
| 10/15/2003 | EP1352958A1 Gene disrupted yeast |
| 10/15/2003 | EP1352912A1 Parathyroid hormone analogues for the treatment of osteoporosis |
| 10/15/2003 | EP1352911A1 Angiotensin converting enzyme inhibitors |
| 10/15/2003 | EP1352656A2 Combination therapy using a TNF binding protein for treating TNF-mediated diseases |
| 10/15/2003 | EP1352242A2 Detection methods |
| 10/15/2003 | EP1352240A2 Cloning and expression of a new mcp receptor in glial cells |
| 10/15/2003 | EP1352092A2 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 10/15/2003 | EP1352091A2 Compositions and methods enabling a totally internally controlled amplification reaction |
| 10/15/2003 | EP1352077A2 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 10/15/2003 | EP1352075A2 Maize yellow stripe1 and related genes |
| 10/15/2003 | EP1352070A2 A fibrin/fibrinogen-binding conjugate |
| 10/15/2003 | EP1352068A2 Bacillus thuringiensis insecticidal proteins |
| 10/15/2003 | EP1352067A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 10/15/2003 | EP1352066A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 10/15/2003 | EP1352065A2 Polypetides and nucleic acids encoding same |
| 10/15/2003 | EP1352064A2 Seleno-cysteine containing protein zsel1 |
| 10/15/2003 | EP1352063A2 Receptor nucleic acids and polypeptides |
| 10/15/2003 | EP1352062A2 Improved growth hormone molecules |
| 10/15/2003 | EP1352056A2 Polypeptides |
| 10/15/2003 | EP1352054A2 Aspergillus ochraceus 11 alpha hydrolase and oxidoreductase |
| 10/15/2003 | EP1352053A2 Method for processing dendritic cells and for activating macrophages with ru 41740 |
| 10/15/2003 | EP1351991A2 Ternary biomolecule/polymer/surface-based immobilization systems |
| 10/15/2003 | EP1351987A2 Hybrid antibodies |
| 10/15/2003 | EP1351986A2 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii |
| 10/15/2003 | EP1351985A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors |
| 10/15/2003 | EP1351984A2 Amidated glucagon-like peptide-1 |
| 10/15/2003 | EP1351983A2 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof |
| 10/15/2003 | EP1351982A2 X ray crystal structures at 5.5 a resolution of functional complexes of the bacterial ribosome containing transfer rna and model messenger rnas |
| 10/15/2003 | EP1351981A2 A virus causing respiratory tract illness in susceptible mammals |
| 10/15/2003 | EP1351980A2 Peptides for activation and inhibition of delta pkc |
| 10/15/2003 | EP1351979A1 Regulated activation of cell-membrane receptors by metal-chelating agonists |
| 10/15/2003 | EP1351978A2 Retrovirus isolated from humans |
| 10/15/2003 | EP1351968A1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 10/15/2003 | EP1351967A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 10/15/2003 | EP1351841A2 Oil maintenance indicator |
| 10/15/2003 | EP1351744A2 Erbb4 antagonists |
| 10/15/2003 | EP1351711A2 Generation and/or reduction of new lung tissue in an affected lung, by modulation of the wnt-pathway |
| 10/15/2003 | EP1351708A1 Therapeutic agent comprising a b-subunit of a protein toxin |
| 10/15/2003 | EP1351704A2 Storage stable powder compositions of interleukin-4 receptor |
| 10/15/2003 | EP1351703A2 Use of a polypeptide comprising the extracellular domains of il-20ra and il-20rb for the treatment of inflammation |
| 10/15/2003 | EP1351702A1 Trem-1 splice variant for use in modifying immune responses |
| 10/15/2003 | EP1351699A1 Methods for improved diagnosis and treatment of mycobacterial infections |
| 10/15/2003 | EP1351648A2 Carrier vectors through an epithelium with tight junctions |
| 10/15/2003 | EP1189627B1 Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies |
| 10/15/2003 | EP0805161B1 (1-3)-beta-d-glucan-binding protein, antibody that recognizes the protein, and use of the protein and antibody |
| 10/15/2003 | EP0796276B1 Gradual modification, super-agonists and antagonists of signal-proteins and peptides |
| 10/15/2003 | EP0716591B1 USE OF ApoE FOR BINDING TAU AND MAP2c PROTEINS AND FOR TREATING ALZHEIMER'S DISEASE |
| 10/15/2003 | EP0706568B1 Vertebrate apoptosis gene: compositions and methods |
| 10/15/2003 | EP0689595B1 Plant promoter, microorganisms and plant cells containing a unit for the expression of a protein of interest comprising said promoter |
| 10/15/2003 | EP0585398B1 Hcv genomic sequences for diagnostics and therapeutics |
| 10/15/2003 | CN1449446A Streptococcus antigens |
| 10/15/2003 | CN1449445A Ev-vegf nucleic acids and polypeptides and methods of use |
| 10/15/2003 | CN1449443A 真菌细胞壁合成基因 Fungal cell wall synthesis genes |
| 10/15/2003 | CN1449441A Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone |
| 10/15/2003 | CN1449440A Masp-2, a complement-fixing enzyme, and uses for it |
| 10/15/2003 | CN1449410A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 10/15/2003 | CN1449409A Promyostatin peptides and methods of using same |
| 10/15/2003 | CN1449250A Novel insecticidal toxins derived from bacillus thuringiensis insecticidal crystal proteins |
| 10/15/2003 | CN1448509A Human ICAM-1 extramembranous I-III domain gene expression product ,its prep. and application in radioimmunological technology |
| 10/15/2003 | CN1448406A Human B lymphocyte stimulating factor mutant and constructing method and coding gene thereof |
| 10/15/2003 | CN1448405A Human truncated recombination soluble TRAIL-170 protein and application for preparing tumour-curing medicine thereof |
| 10/15/2003 | CN1448404A Human truncated recombination soluble TRAIL-180 protein and application for preparing tumour-curing medicine thereof |
| 10/15/2003 | CN1448403A Human protein with cancer cell growth suppressing function and its coding sequence |
| 10/15/2003 | CN1448402A Polypeptide-human anemia related protein 35.4 and polynucleotide for coding said polypeptide |
| 10/15/2003 | CN1448401A Protein related to plant cell cycle and its coding gene |
| 10/15/2003 | CN1448398A Cotton bollworm molt-regulating transcription factor cDNA and cloning method and recombination application thereof |
| 10/15/2003 | CN1448065A Protein extracting and separating method from defatted cotton dregs |
| 10/15/2003 | CN1124348C Multi-functional hematopoietic receptor agonists |
| 10/15/2003 | CN1124346C Novel yeast genes |
| 10/15/2003 | CN1124343C Brain derived naurotrophic factor |
| 10/15/2003 | CN1124342C Neurotrophin-3, neurotrophic factor related to nerve growth and brain derived neurotrophic factor |
| 10/15/2003 | CN1124339C Novel cell surface protein |
| 10/15/2003 | CN1124283C Peptide, bronchodilator and blood flow ameliorant |
| 10/15/2003 | CN1124282C Conformationally constrained backbone cyclized somatostatin analogs |
| 10/15/2003 | CN1124159C Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 10/14/2003 | US6632981 Transgenic plants and tissues with chimeric construction; gene expression control |
| 10/14/2003 | US6632980 Chromosomally-integrated inactive replicon derived from geminiviruses and single-stranded RNA viruses; cis-acting viral elements for replication; target gene with regulatory sequence |
| 10/14/2003 | US6632977 Transgenic animal whose expression of the opiate receptors is modified |
| 10/14/2003 | US6632937 Nucleic acids and proteins from Cenarchaeum symbiosum |
| 10/14/2003 | US6632935 Genome DNA of bacterial symbiont of aphids |
| 10/14/2003 | US6632934 MORC gene compositions and methods of use |
| 10/14/2003 | US6632929 Avidin derivatives and uses thereof |